American investors have spent years betting that Tesla, Figure, or 1X would define the humanoid robot race. The 2025 shipment numbers tell a different story.
Chinese startups took every one of the top six spots in the global rankings and are putting robots into factories and shopping malls while their US competitors are still in development. The gap isn't about talent or ambition.
It's about where the money goes.
Omdia tracks global humanoid robot shipments annually, and for 2025, the top six companies by shipment volume are all Chinese. That's not because the US isn't trying.
It's because Chinese firms moved faster from lab work to factory floor deployment, which is the step that separates a demo from a business.
The most prominent Chinese name is AI2 Robotics, now valued at 20 billion yuan, or roughly $2.93 billion. A foreign high-end manufacturer recently chose AI2 over a US startup to supply robots for factory work, which is the kind of contract that signals a company has crossed from prototype to product.
Middle East sovereign wealth funds are also stepping in as buyers and backers. They're investing in Chinese robotics VC funds and purchasing Chinese-built humanoid robots directly for infrastructure projects.
That combination of capital and end-market demand is reinforcing the Chinese lead.
The answer is where US capital flows. Roughly 90% of US venture capital goes into software, leaving hardware - and especially hard-to-scale hardware like humanoid robots - with a much smaller share of the funding pool.
That creates a structural mismatch that's difficult to overcome on engineering merit alone. US software remains the best in the world, but the physical machines needed to run it are being built elsewhere.
Some American engineers are now traveling to Shenzhen to buy robot parts, then combining them with US-developed software stacks back home. That arrangement works at a small scale.
It doesn't work for large-volume deployments. The names getting most of the US robot industry attention - Tesla's Optimus program, Figure AI, 1X - are all still pushing development timelines.
None have shipped at anywhere close to Chinese volumes yet. For all three, the next 18 months will be about whether they can move from announcement to delivery at scale.
The financing gap: Sovereign wealth capital is stepping into the hardware void that US venture is leaving open. That makes the humanoid race as much a capital-structure question as an engineering one.
For investors, the story is about supply chain positioning more than pure-play stocks. Public market exposure to the humanoid robot theme still runs largely through component suppliers - actuators, sensors, semiconductors, battery systems - rather than through the robot makers themselves.
Chinese dominance in shipments reinforces the argument for those component suppliers, which sell regardless of whose robots win. The longer-term question is whether US venture capital will shift back toward hardware in response to the Chinese lead.
If it does, the funding gap narrows. If it doesn't, the gap widens further and Chinese firms cement their position in the fastest-growing robotics segment.
Watch Tesla's Optimus rollout timeline along with any production updates from Figure AI and 1X. If any of those three can deliver meaningful volume in 2026, the US position improves quickly.
If another year passes with prototypes and demos, Chinese shipment dominance becomes the base case for the rest of the decade. For investors, sovereign wealth activity is worth tracking too.
Middle East funds in particular are reshaping the capital map for robotics, and their allocations signal where the next wave of factory automation spending will land.
